Trial to Evaluate the Effect of ALN-PCSSC Treatment on Low Density Lipoprotein Cholesterol (LDL-C)

NCT02597127 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

501

Enrollment

INDUSTRY

Sponsor class

Conditions

Atherosclerotic Cardiovascular Disease
Familial Hypercholesterolemia
Diabetes

Interventions

DRUG: ALN-PCSSC
DRUG: Normal Saline

Sponsor

The Medicines Company